A freeze dried fraction of Avian Infectious Laryngotracheitis virus, Salsbury strain 146, ≥ 102.5 EID50 per dose.

For the prevention of mortality and clinical signs due to infection with avian infectious laryngotracheitis virus. Onset of immunity is 14 days post vaccination. Duration of immunity has not been assessed, however, experience from field use indicates that once vaccinated birds remain immune to avian infectious laryngotracheitis virus infection during entire laying period.

Vaccine is administered to chickens from 4 weeks of age by eye drop.

1000 doses of freeze dried vaccine must be completely dissolved in 30ml of the sterile diluent provided and a drop of dispenser calibrated to deliver at least three hundredth of a millilitre per drop must be used. Remove the rubber stopper from the vaccine vial and add sterile diluent to half fill the vial. Replace the rubber stopper and shake gently so that all the vaccine material is completely dissolved.

Pour the dissolved vaccine into the remaining sterile diluent and shake again until completely mixed. The sterile diluent should be at room temperature when used. Fit the drop dispenser on the bottle. Hold the bird so that one eye is pointing upwards and allow one drop of vaccine to fall into the eye.

Use clean vaccination materials.

Contact with disinfectants makes the vaccine ineffective.

Protect the reconstituted vaccine from heat or direct sunlight.

For animal treatment only.

Do not vaccinate diseased birds (except in case of an emergency vaccination).

Do not use in laying chickens.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be decided on a case by case basis.

Do not mix with any other veterinary medicinal product.

In order to prevent spread of vaccine strain from vaccinated flocks to non-vaccinated flocks, all non-vaccinated birds present on the farm must be vaccinated at the same time.

About four days after vaccination, redness and some swelling of the conjunctiva, or laboured breathing may be seen. Under good hygienic conditions, this reaction will not last longer than three days.

Administration of an overdose does not result in significantly worse adverse reactions to those seen after administration of a single dose.

Zero days.

Store and transport at 2°C to 8°C.

Protect from light. Do not freeze.

Keep out of reach and sight of children.

Vaccine: packs of 10 vials containing 1,000 doses.

Diluent: packs of 10 x 30ml vials.

Dispose of waste materials by boiling, incineration or immersion in an appropriate disinfectant approved for use by the competent authorities.

Vm 42058/4106